IRESS LIMITED (IRE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IRE

IRE - IRESS LIMITED

Year End: December
GICS Industry Group : Software & Services
Debt/EBITDA: 2.32
Index: ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Iress is an Australian financial technology company providing information software products to the global finance industry. Founded in 1993, it listed on the ASX in 2000.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$9.09

14 Aug
2025

0.290

OPEN

$8.85

3.30%

HIGH

$9.17

1,614,021

LOW

$8.81

TARGET
$9.73 7.0% upside
Franking for last dividend paid out: 50%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CGF . CVW . DJW . ENN . GDG . GQG . HMC . HUB . IFL . IFT . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . PTM . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
IRE: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 48.0 35.5 xxx
DPS (cps) xxx 10.0 21.1 xxx
EPS Growth xxx N/A - 26.1% xxx
DPS Growth xxx N/A 100.0% xxx
PE Ratio xxx N/A 25.5 xxx
Dividend Yield xxx N/A 2.3% xxx
Div Pay Ratio(%) xxx 20.8% 59.6% xxx

Dividend yield today if purchased 3 years ago: 0.88%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.11

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 23/02 - ex-div 30c (franking 0%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx48.0
DPS All xxxxxxxxxxxxxxx10.0
Sales/Revenue xxxxxxxxxxxxxxx600.8 M
Book Value Per Share xxxxxxxxxxxxxxx204.6
Net Operating Cash Flow xxxxxxxxxxxxxxx104.6 M
Net Profit Margin xxxxxxxxxxxxxxx14.76 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx27.28 %
Return on Invested Capital xxxxxxxxxxxxxxx14.48 %
Return on Assets xxxxxxxxxxxxxxx11.65 %
Return on Equity xxxxxxxxxxxxxxx27.28 %
Return on Total Capital xxxxxxxxxxxxxxx8.33 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx94.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx68 M
Long Term Debt xxxxxxxxxxxxxxx166 M
Total Debt xxxxxxxxxxxxxxx234 M
Goodwill - Gross xxxxxxxxxxxxxxx411 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx66 M
Price To Book Value xxxxxxxxxxxxxxx4.55

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx24.1 M
Capex % of Sales xxxxxxxxxxxxxxx4.01 %
Cost of Goods Sold xxxxxxxxxxxxxxx477 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx70 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

xx/xx/xxxx

1

xxx, xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

2

xxxxxxxxx xx xxxxxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

12/08/2025

-1

No Rating

-

Macquarie believes Iress' core business is performing well enough to offset lost revenue from divested units and higher R&D spending. 

The company reaffirmed FY25 guidance despite divestments and provided FY28 targets, expecting 6% revenue growth per year, increasing to 8% over time.

Non-recurring revenue growth is expected to support revenue growth in future periods.

The broker cut FY25 EPS forecast by -9.4%, FY26 by -7.5% and FY27 by -4.9% after updating revenue and margins forecasts, and divestments.

No rating or target price as the broker is under research restriction.

FORECAST
Macquarie forecasts a full year FY25 dividend of 23.00 cents and EPS of 34.80 cents.
Macquarie forecasts a full year FY26 dividend of 25.00 cents and EPS of 38.70 cents.

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

14/08/2025

1

Overweight

$10.00

10.01%

Wilsons observes there were too many details in Iress' 1H25 result, arguing key messages unfortunately got lost within, but the main positive was accelerating revenue growth, belying market scepticism.

FY25 adjusted EBITDA guidance was reiterated, with implication it will be 2H-weighted to achieve the top end of the $127-135m range. If this is achieved, the broker will be more comfortable with its $140m adjusted EBITDA estimate for FY26.

Still, there was a downgrades to FY25-26 forecasts due to removal of loss-making Quanthouse and higher effective tax rates.

Target price unchanged at $10 due to private equity interest in the company. Overweight retained.

FORECAST
Wilsons forecasts a full year FY25 dividend of 35.00 cents and EPS of 35.20 cents.
Wilsons forecasts a full year FY26 dividend of 41.00 cents and EPS of 40.20 cents.

IRE STOCK CHART